Overview

A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel

Status:
Completed

Trial end date:
2007-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the optimal tolerated regime of PEP005 for the treatment of actinic keratoses of the face or face and scalp.

Phase:

Phase 2

Details

Lead Sponsor:

Peplin